These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16141951)

  • 1. Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine.
    Burstein R; Levy D; Jakubowski M
    Rev Neurol (Paris); 2005 Jul; 161(6-7):658-60. PubMed ID: 16141951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.
    Bernstein C; Burstein R
    J Clin Neurol; 2012 Jun; 8(2):89-99. PubMed ID: 22787491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central sensitisation and cutaneous allodynia in migraine: implications for treatment.
    Landy S; Rice K; Lobo B
    CNS Drugs; 2004; 18(6):337-42. PubMed ID: 15089101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The science of migraine.
    Burstein R; Jakubowski M; Rauch SD
    J Vestib Res; 2011; 21(6):305-14. PubMed ID: 22348935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine.
    Burstein R; Cutrer MF; Yarnitsky D
    Brain; 2000 Aug; 123 ( Pt 8)():1703-9. PubMed ID: 10908199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing migraine associated with sensitization.
    Burstein R; Jakubowski M
    Handb Clin Neurol; 2010; 97():207-15. PubMed ID: 20816422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.
    Burstein R; Jakubowski M
    Ann Neurol; 2004 Jan; 55(1):27-36. PubMed ID: 14705109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.
    Lambert GA; Davis JB; Appleby JM; Chizh BA; Hoskin KL; Zagami AS
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):311-25. PubMed ID: 19690836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine pathophysiology and its clinical implications.
    Silberstein SD
    Cephalalgia; 2004; 24 Suppl 2():2-7. PubMed ID: 15595988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanism of peripheral and central sensitization in migraine. A literature review].
    Tajti J; Vécsei L
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):15-21. PubMed ID: 19731814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine.
    Ghelardini C; Galeotti N; Grazioli I; Uslenghi C
    J Pain; 2004 Oct; 5(8):413-9. PubMed ID: 15501422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of migraine--new insights.
    Hargreaves RJ; Shepheard SL
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S12-9. PubMed ID: 10563228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.
    Levy D; Jakubowski M; Burstein R
    Proc Natl Acad Sci U S A; 2004 Mar; 101(12):4274-9. PubMed ID: 15016917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain.
    Noseda R; Burstein R
    Pain; 2013 Dec; 154 Suppl 1():S44-53. PubMed ID: 23891892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitroglycerine triggers triptan-responsive cranial allodynia and trigeminal neuronal hypersensitivity.
    Akerman S; Karsan N; Bose P; Hoffmann JR; Holland PR; Romero-Reyes M; Goadsby PJ
    Brain; 2019 Jan; 142(1):103-119. PubMed ID: 30596910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology of migraine and clinical implications].
    Schürks M; Diener HC
    Schmerz; 2008 Oct; 22(5):523-6, 528-30. PubMed ID: 18600349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.
    Akerman S; Romero-Reyes M
    Expert Rev Neurother; 2013 Sep; 13(9):1041-59. PubMed ID: 23952299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous allodynia and migraine: another view.
    Dahlöf C
    Curr Pain Headache Rep; 2006 Jun; 10(3):231-8. PubMed ID: 18778579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated noxious stimulation of the skin enhances cutaneous pain perception of migraine patients in-between attacks: clinical evidence for continuous sub-threshold increase in membrane excitability of central trigeminovascular neurons.
    Weissman-Fogel I; Sprecher E; Granovsky Y; Yarnitsky D
    Pain; 2003 Aug; 104(3):693-700. PubMed ID: 12927642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.